======= NT5C =======
== Gene Information ==
* **Official Symbol**: NT5C
* **Official Name**: 5', 3'-nucleotidase, cytosolic
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30833|30833]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8TCD5|Q8TCD5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NT5C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NT5C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/191720|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Dephosphorylates the 5' and 2'(3')-phosphates of deoxyribonucleotides, with a preference for dUMP and dTMP, intermediate activity towards dGMP, and low activity towards dCMP and dAMP.
|NT5C|
|pyrimidine nucleotide binding|
|nucleotidase activity|
|pyrimidine deoxyribonucleotide catabolic process|
|pyrimidine nucleotide catabolic process|
|5-nucleotidase activity|
|deoxyribonucleotide catabolic process|
|pyrimidine deoxyribonucleotide metabolic process|
|deoxyribose phosphate catabolic process|
|pyrimidine nucleoside catabolic process|
|2-deoxyribonucleotide metabolic process|
|deoxyribose phosphate metabolic process|
|nucleoside catabolic process|
|deoxyribonucleotide metabolic process|
|pyrimidine nucleoside metabolic process|
|pyrimidine-containing compound catabolic process|
|purine nucleotide catabolic process|
|glycosyl compound catabolic process|
|nucleobase-containing small molecule catabolic process|
|purine-containing compound catabolic process|
|pyrimidine nucleotide metabolic process|
|nucleotide catabolic process|
|nucleoside phosphate catabolic process|
|pyrimidine-containing compound metabolic process|
|nucleobase-containing small molecule biosynthetic process|
|nucleoside metabolic process|
|organophosphate catabolic process|
|glycosyl compound metabolic process|
|carbohydrate derivative catabolic process|
|dephosphorylation|
|purine nucleotide metabolic process|
|purine-containing compound metabolic process|
|nucleobase-containing compound catabolic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|small molecule catabolic process|
|aromatic compound catabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|organic cyclic compound catabolic process|
|nucleobase-containing small molecule metabolic process|
|small molecule biosynthetic process|
|organophosphate metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.32|
|[[:results:exp519|RS-1 10μM R08 exp519]]|-1.82|
|[[:results:exp433|LJH685 50μM R08 exp433]]|1.8|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11881
* **Expression level (log2 read counts)**: 3.93
{{:chemogenomics:nalm6 dist.png?nolink |}}